While PI3Kδ is predominantly expressed in immune cells, gain-of-function mutations can cause hyperactivation of the mTOR pathway, contributing to disorders like activated PI3K-δ syndrome (APDS) and certain cancers [105]. This evidence concerns the gene MTOR and cancer.